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Abstract
Our previous studies have shown the role of radiation-induced urokinase plasminogen activator (uPA) expression in
the progression of meningioma. In the present study, we investigated whether modulation of DNA methylation pro-
files could regulate uPA expression. Initially, radiation treatment was found to induce hypomethylation in meningioma
cells with a decrease in DNA (cytosine-5)-methyltransferase 1 (DNMT1) and methyl-CpG binding domain protein
(MBD) expression. However, oxidative damage by H2O2 or pretreatment of irradiated cells with N -acetyl cysteine
(NAC) did not show any influence on these proteins, thereby indicating a radiation-specific change in the methylation
patterns among meningioma cells. Further, we identified that hypomethylation is coupled to an increase in uPA
expression in these cells. Azacytidine treatment induced a dose-dependent surge of uPA expression, whereas pre-
treatment with sodium butyrate inhibited radiation-induced uPA expression, which complemented our prior results.
Methylation-specific polymerase chain reaction on bisulfite-treated genomic DNA revealed a diminished methylation
of uPA promoter in irradiated cells. Transfection with small hairpin RNA (shRNA)-expressing plasmids targeting CpG
islands of the uPA promoter showed a marked decline in uPA expression with subsequent decrease in invasion and
proliferation ofmeningioma cells. Further, radiation treatmentwas found to recruit SP1 transcription factor, whichwas
abrogated by shRNA treatment. Analysis on signaling events demonstrated the activation of MAP kinase kinase
(MEK)-extracellular signal-regulated kinase (ERK) in radiation-treated cells, while U0126 (MEK/ERK inhibitor) blocked
hypomethylation, recruitment of SP1, and uPA expression. In agreement with our in vitro data, low DNMT1 levels and
high uPA were found in intracranial tumors treated with radiation compared to untreated tumors. In conclusion, our
data suggest that radiation-mediated hypomethylation triggers uPA expression in meningioma cells.
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Introduction
DNA methylation is essential for growth, development, and environ-
mental responsiveness of mammalian cells. Cellular phenomena such
as changes in gene expression, chromatin structure alterations, acti-
vation of transposable elements, genomic imprinting, and carcino-
genesis have been shown to occur along with DNA methylation
[1]. Both hypomethylation and hypermethylation of genomic DNA
induce significant epigenetic and genetic changes in the cell [2]. It is
increasingly apparent that cancer development depends not only on
genetic alterations but also on a heritable cellular memory or epi-
genetic changes that are critical for tumor initiation and progression
[3]. From an epigenetics perspective, during carcinogenesis, DNA
undergoes genome-wide hypomethylation and regional hypermethyl-
ation of CpG islands in tandem, offering perspective advantage for the
preliminary tumor cell. Localized hypermethylation, which represses
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transcription of the promoter regions of tumor suppressor genes, and
global hypomethylation have been recognized as strategic events that
typify many cancers. There are several protective mechanisms that
prevent the hypermethylation of the CpG islands including active
transcription, active demethylation, replication timing, and local
chromatin structure, thereby preventing access to the DNA methyl-
transferase. However, the mechanisms by which hypomethylation
contributes to malignancy are oncogene activation, loss of imprinting,
and promotion of genomic instability through unmasking of repetitive
elements. Hypomethylation is common in solid tumors such as meta-
static hepatocellular cancer, cervical cancer, and prostate tumors, as
well as hematologic malignancies such as B cell chronic lymphocytic
leukemia [4]. A number of cancers, such as breast, cervical, and brain,
usually show a progressive increase of hypomethylation corresponding
with the grade of malignancy. New information about the mechanism
of methylation and its control has led to the discovery of many reg-
ulatory proteins and enzymes. All evidence indicates that the DNA
(cytosine-5)-methyltransferase 1 (DNMT1) enzyme acts as a main-
tenance methyltransferase to prevent binding of transcription factors,
whereas methyl-CpG binding domain protein 1 (MBD), MBD2,
methyl CpG-binding protein 2 (MeCP2), and Kaiso have been shown
to repress transcription of target genes.
It has been acknowledged for many years that radiation exposure
induces delayed nontargeted effects in the progeny of the irradiated
cell. Evidence is beginning to demonstrate that among these delayed
effects of radiation are epigenetic aberrations including altered DNA
methylation [5]. Although somewhat preliminary, multiple studies
have shown how signaling events are involved in abnormal DNA
methylation in cancer. Many signal transduction pathways that drive
cell transformation and tumor progression lead to the up-regulation
of CpG and/or components of the DNA methylation machinery
[6]. Specifically, increased methylation of the urokinase plasmin-
ogen activator (uPA) promoter was found to associate significantly
with lower levels of uPA and the transcription pattern of uPA in
meningiomas; this might, in part, be controlled by promoter meth-
ylation [7]. Recent studies provide evidence that RNA interference
can also direct DNA methylation and transcriptional gene silencing
(TGS) in human cells [8–10], thereby suggesting a potential and
additional mechanism for transcriptional regulation in mammals.
Data are also accruing for a central role of transcription factors in
epigenetically regulated processes. These processes include control
of organization and placement of proteins that determine accessibility
and transcriptional competency of genomic sequences for expres-
sion. As such, these processes support proliferation, growth, pheno-
type, and homeostatic regulation at both the transcriptional and the
post-transcriptional levels [11]. Further, DNA methylation has been
shown to determine access of transcription factors to gene regulatory
sequences [11].
We have reported a radiation-induced overexpression of uPA in
meningioma cells, which could only partly be attributed to mitogen-
activated protein kinase (MAPK) signaling, suggesting additional level
of regulation [15,16]. However, methylated promoter was shown to
have significant negative correlation with uPA expression in menin-
gioma [7] and radiation treatment was shown to induce epigenetic
aberrations in human cells [5]. Therefore, we hypothesized that
radiation-induced uPA expression in meningioma could be a result of
hypomethylation. We performed this study to demonstrate that changes
in the promoter methylation patterns do indeed contribute to meningioma
progression in vitro and in vivo.
Materials and Methods
Cell Culture
We used the human meningioma IOMM-Lee and SF3061 cell lines
(kindly provided by Dr Ian E. McCutcheon, University of Texas
M.D. Anderson Cancer Center, Houston, TX, and Dr Anitha Lal,
University of California, San Francisco, CA, respectively). Both
cell lines were maintained in Dulbecco’s modified Eagle’s medium
(Thermo Scientific, San Jose, CA) supplemented with 10% FBS,
100U/ml streptomycin, and 100U/ml penicillin (Invitrogen, Carlsbad,
CA). Cells were maintained in a humidified atmosphere containing
5% CO2 at 37°C. Cells were treated with zebularine (VWR Scientific,
Chicago, IL), azacytidine, sodium butyrate, and U0126 and incu-
bated for the indicated period of time in complete medium. DNMT1,
phospho extracellular signal-regulated kinase (pERK), ERK, MEK,
phospho MAP kinase kinase (pMEK), cRaf, pcRAF, uPA, and glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH) antibodies and
HRP-conjugated secondary antibodies were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA).
Radiation Treatment
The RS 2000 Biological Irradiator (Rad Source Technologies, Inc,
Boca Raton, FL) X-ray unit operated at 150 kV/50 mA and deliver-
ing 0.71 Gy/min was used for radiation treatments. Cells were given
a single dose of 7-Gy radiation, and for experiments involving the
inhibitors, radiation was given after 1 hour of inhibitor treatment.
Construction of Small Hairpin RNA Plasmids
The uPA promoter was identified on the 10th chromosome. About
10,000 bases upstream of the transcription site were annotated for the
presence of promoter-specific elements. The promoter sequence was
predicted using The Markov Chain Promoter Prediction Server, which
is freely available for the public’s use from Duke University (Durham,
NC). The predicted sequences were screened with a cutoff of 0.90 and
1.0 being the highest. The presence of CpG islands were defined as
sequence ranges that give a y value of greater than 0.6 and a guanine-
cytosine (GC) content of greater than 50% using sequence manipula-
tion suite (Stothard 2000). The plasmid vector, pSilencer 4.1-CMV
(Ambion, Austin, TX), was used in the construction of the shRNA-
expressing vector, and the human uPA promoter sequence rich in CpG
islands AGGAAGCACGGAGAATTTACAAG was the shRNA target
sequence. Inverted repeat sequences were synthesized. The inverted
repeats were laterally symmetrical, making them self-complimentary
with a 9-bp mismatch in the loop region that would aid in the loop for-
mation of the shRNA. Oligonucleotides were heated in a boiling water
bath in 6× SSC for 5 minutes and self-annealed by slow cooling to room
temperature. The annealed oligonucleotides were ligated to pSilencer
vector at BamHI and HindIII sites. Cells at 60% to 70% confluence in
100-mm tissue culture plates were transfected with 7 μg of shRNA-
expressing plasmid constructs using FuGENE HD following the manu-
facturer’s instructions (Roche Applied Science, Indianapolis, IN).
Transfection Studies
All transfection experiments were performed with FuGENE HD
transfection reagent as per the manufacturer’s protocol (Roche Applied
Science). IOMM-Lee and SF3061 cells were transfected with plasmid
constructs containing scrambled sequence [scrambled vector (SV)] or
shRNA for uPA promoter (puPA)–expressing sequences. After 6 hours
of transfection, complete medium was added, and cells were incubated
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for 36 hours. Later, the cells were irradiated (7 Gy) and incubated
overnight before being subjected to further analysis.
Fibrin Zymography
Conditioned media containing 0.1 μg (IOMM-Lee) and 5.0 μg
(SF3061 cells) of protein from different experiments were subjected
to zymography. Samples were resolved on 10% sodium dodecyl
sulfate–polyacrylamide gel electrophoresis containing plasminogen
and fibrinogen and stained as described previously [12].
Matrigel Invasion Assay
Invasion assays were performed in Boyden chambers, using 8-μm
pore size polyvinyl pyrrolidone-free (PVDF) polycarbonate matrigel–
coated filters. IOMM-Lee and SF3061 cells from different treatment
groups were added in the upper chamber in serum-free medium,
and complete medium was added in the lower chamber. Cells were
allowed to migrate overnight at 37°C and 5% CO2. Cells on the
lower surface of the filter were then fixed in ethanol, stained with
hematoxylin, and observed under a light microscope [12].
Western Blot Analysis
Cells were collected from treated and untreated experimental
groups. Cell lysates were prepared in RIPA buffer and nuclear extracts
were prepared using nuclear extraction buffer. Equal amounts of pro-
tein were then subjected to sodium dodecyl sulfate–polyacrylamide gel
electrophoresis using gels with appropriate percentage of acrylamide
followed by transfer of protein to nitrocellulose membranes (Bio-
Rad, Hercules, CA). Membranes were processed with primary anti-
bodies at a 1:1000 dilution and HRP-conjugated secondary antibodies
at a 1:2000 dilution as described previously [13]. The membranes
were developed following an enhanced chemiluminescence protocol
(Amersham Biosciences, Piscataway, NJ) and were further probed for
GAPDH, which was used as a loading control.
Bisulfite Conversion
The genomicDNA from IOMM-Lee and SF3061 cells was extracted
using DNeasy Blood And Tissue Kit (Qiagen, Valencia, CA) following
the manufacturer’s recommendations. Equal quantities of DNA were
subjected to bisulfite conversion using EpiTect Bisulfite Kit (Qiagen).
3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyl Tetrazolium
Bromide (MTT) Proliferation Assay
IOMM-Lee and SF3061 cells seeded in six-well plates were treated
with different agents and irradiated as described earlier. Six hours later,
cells were trypsinized, counted, and seeded at 1 × 104 cells per well in
96-well plates (three wells per treatment group). After the indicated hours
of incubation in conditioned medium, 20 μl of MTT reagent was added
to the cells, followed by another 4 hours of incubation at 37°C. Acid-
isopropanol (0.04 MHCl/isopropanol) was added to all wells and mixed
vigorously so that the formazan crystals dissolved effectively. Absorbance
was measured on a microtiter plate reader (Model 680; Bio-Rad) with
a test wavelength of 550 nm and a reference wavelength of 655 nm.
Reverse Transcription–Polymerase Chain Reaction
Total RNA extracted from frozen brain tissues and meningioma cells
was subjected to cDNA synthesis using Transcriptor First Strand cDNA
Synthesis Kit (Roche Applied Science). Polymerase chain reaction (PCR)
was performed using primers specific for human uPA, DNMT1,MeCP,
and MBD2, and products were analyzed on 1.8% agarose gels.
Methylation-Specific PCR
DNA was extracted using standard methods (Qiagen DNA Kit)
from meningioma cells or snap-frozen tumor tissues and subjected
to bisulfite treatment with the EpiTect Bisulfite Kit (Qiagen) in accor-
dance with the manufacturer’s recommended procedure. A 365-bp
(−430 to −66) or a 131-bp fragment (−145 to −14) of the uPA promoter
(NCBI Reference Sequence: NG_011904.1: 4596–4960) was PCR-
amplified using methylation-specific (MS) primers or unmethylated-
specific (UM) primers.
Restriction Digestion
The selected 131-bp uPA promoter contains three potential Sp1
binding sites that are part of AciI recognition sites; these AciI sites are
destroyed by bisulfite treatment unless protected by CpG methyla-
tion. Hence, the band pattern after AciI restriction will reflect the
degree of methylation of this region. Increasing levels of DNA meth-
ylation will result in AciI digest and smaller DNA fragments. The
amplicons obtained from pSV-transfected cells using MS primers
and those from irradiation (IR)-treated cells using UM primers were
purified (Qiagen Gel Extraction Kit). A 25-μl reaction containing
250 ng of DNA and 10 units of AciI was incubated for 3 hours
at 37°C and the enzyme was inactivated as per the manufacturer’s
recommendation. The resultant mixtures were analyzed on 2% agarose
gels, and the patterns of digestion were documented.
Immunocytochemistry
IOMM-Lee cells and SF3061 cells (5 × 103) were seeded onto
eight-well chamber slides and transfected with puPA or pSV. Twenty-
four hours after transfection, cells were irradiated and incubated over-
night. The cells were washed, fixedwith 4%buffered paraformaldehyde,
and permeabilized with freshly prepared 0.1%Triton X-100 containing
0.1% sodium citrate. Later, the cells were blocked with 2% BSA for
1 hour followed by overnight incubation with uPA antibody (1:100
dilution) at 4°C. Next, the chamber slides were treated with HRP-
conjugated secondary antibodies (1:200) for 45 minutes at room tem-
perature. Immunolocalization was accomplished by exposing sections
to 0.05% 3,3-diaminobezidine tetrahydrochloride as the chromogen.
All microscopy studies were performed using a microscope attached
to a closed circuit (CC) camera.
In Vivo Studies
The Institutional Animal Care and Use Committee at the University
of Illinois College ofMedicine in Peoria approved all experimental proce-
dures involving the use of animals. Intracranial implantation of menin-
gioma cells was accomplished as described previously [14]. Irradiated cells
were allowed to recover for 72 hours with a regular replenishment of
fresh medium every 24 hours and infused into one group of animals
(n = 9). Nude mice infused with nonirradiated cells served as controls
for the respective groups. The animals were observed for changes in
morphologic characteristics for 4 weeks. After 4 weeks, the brains were
harvested and either snap frozen or fixed in formalin for further analysis.
Immunohistochemistry
Sections of formalin-fixed and paraffin-embedded brain tissue were
subjected to hematoxylin and eosin (H&E) staining to verify tumor
formation and immunostaining for cyclin B1 (1:100 dilution) and
HRP-conjugated secondary antibody (1:200 dilution) as described
elsewhere [15].
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Statistical Analysis
All data are presented as means ± SEs of at least three independent
experiments (each performed at least in triplicate). One-way analysis
of variance combined with the Tukey post-hoc test of means were
used for multiple comparisons of cell culture experiments. Statistical
differences are presented at probability levels of P < .05.
Results
Radiation Induces Hypomethylation of the
uPA Promoter in Meningioma
Our previous studies have demonstrated that radiation induces
uPA expression at both the protein and transcript levels in meningi-
oma cells [16]. In the present study, we questioned whether hypo-
methylation has any role in this radiation-induced expression of uPA.
To this end, we analyzed the methylation pattern of the uPA pro-
moter by MS PCR (MSP) using primers designed specifically to
amplify the converted sequence within the uPA promoter upstream
to the TATA box. Genomic DNA extracted from IOMM-Lee and
SF3061 cells was subjected to bisulfite conversion, and then MSP
was performed. A significant decrease (more than two-fold) in the
methylation within CG dinucleotides (indicated by higher band inten-
sity) of uPA promoter was observed in both cell lines, suggesting that
X-rays can induce hypomethylation in vitro (Figure 1, A and B ). We
continued our investigation to determine the enzymes and proteins
that support methylation of DNA. Reverse transcription (RT)–PCR
analysis for DNMT1, MBD, and MeCP2 revealed that these fac-
tors were adversely affected by radiation treatment (Figure 1C ). The
decrease in the levels was drastic, with DNMT1 showing maximum
response compared to MBD and MeCP2 (Figure 1, C and D). Since
Figure 1. Radiation induces hypomethylation of uPA promoter in meningioma. (A) Genomic DNA extracted from control and irradiated
meningioma cells (1.5 × 105) was subjected to bisulfite conversion followed by MSP targeting the uPA promoter and agarose gel analysis.
(B) The band intensities were quantified with ImageJ software and represented in arbitrary units. (C) Total RNA extracted from control and
irradiated meningioma cells (1.5 × 105) was subjected to cDNA conversion followed by RT-PCR and agarose gel analysis. (D) The band
intensities were quantified with ImageJ software and represented as arbitrary units. (E) IOMM-Lee and SF3061 (1 × 105) cells were treated
with sodium butyrate (2 mM) for 24 hours before irradiation. Bisulfite-treated genomic DNA was subjected to MSP and followed by agarose
gel analysis. (F) Band intensities were quantified by ImageJ software as arbitrary units. (G) IOMM-Lee and SF3061 (1 × 105) cells were
treated with sodium butyrate (2 mM) for 24 hours before irradiation, and then MTT assays were performed for 72 hours at 24-hour intervals.
Mean absorbance values were plotted against time. (H) IOMM-Lee and SF3061 (1 × 105) cells were treated with H2O2 (150 mM) and 7-Gy
radiation as indicated. After overnight incubation, the cell lysates were prepared and analyzed for uPA and DNMT1 byWestern blot analysis.
GAPDH served as a loading control. Each blot/image is representative of three independent experiments, and each column represents a
mean of three values (asterisk represents significant value of P < .05).
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the methylation of CpG sites within the uPA promoter was shown to
reversibly inactivate transcription of uPA gene, we next used sodium
butyrate to methylate the uPA promoter in these cells. Cells pretreated
with sodium butyrate showed an apparent increase in the methylation
of the uPA promoter (indicated by decrease in the band intensity),
suggesting the reversible nature of promoter methylation and substan-
tiating hypomethylation as a key event in radiation treatment (Figure 1,
E and F ). Next, we performed cell proliferation assays on sodium
butyrate–treated cells to determine the effect of hypermethylation on
cell survival. After 72 hours of treatment, we noticed a drastic decrease
in the number of cells, while untreated and irradiated cells continue to
divide at markedly different rates (Figure 1G ). We then extended our
studies to confirm whether oxidative damage, which is often associated
with radiation treatment, had any role in DNA demethylation and uPA
expression. Treatment with hydrogen peroxide did not result in any
difference in uPA or DNMT1 expression patterns, as confirmed by
immunoblot analysis (Figure 1H). Similarly, pretreatment of cells with
N -acetyl-L-cysteine also did not result in any significant change in
expression profiles (data not shown).
Hypomethylation Is Linked to uPA Expression in Meningioma
To determine whether demethylation of the uPA promoter is
responsible for induction of uPA expression in these tumors, we tested
the culture supernatants of IOMM-Lee and SF3061 cells treated with
azacytidine and radiation for uPA activity. Treatment with azacytidine
increased uPA activity in both cell lines compared to the untreated
controls (Figure 2A). The increase of uPA activity in azacytidine-treated
cells was significant and greater than five-fold in these cells (Figure 2, A
and B). Radiation treatment enhanced uPA levels in untreated cells,
whereas azacytidine and radiation did not further increase uPA activity
(Figure 2, A and B). These results suggest that radiation-augmented
uPA expression is a result of hypomethylation.
Figure 2. Hypomethylation is linked to uPA expression in meningioma. (A) IOMM-Lee and SF3061 (1 × 105) cells were treated with
azacytidine (10 μM) for 24 hours before irradiation followed by incubation in serum-free medium overnight. Conditioned media were
collected and 0.1 μg of protein was analyzed for uPA activity using fibrin zymography. (B) The band intensities were quantified and
represented as arbitrary units. (C) IOMM-Lee and SF3061 (1 × 105) cells were treated with sodium butyrate (2 mM) for 24 hours before
irradiation. Conditioned media were subjected to fibrin zymography, total RNA was used to perform RT-PCR, and cell lysates were used
for immunoblot analysis. (D) The band intensities were quantified and represented as arbitrary units. (E) IOMM-Lee and SF3061 (1 × 105)
cells were treated with zebularine for 24 hours. Total RNA was used to perform RT-PCR, and cell lysates were used for immunoblot
analysis for uPA. (F) The band intensities were quantified and represented as arbitrary units. (G) Meningioma cells were pretreated with
zebularine (50 μM) for 24 hours, and the cell lysates were used to perform immunoblot analysis for uPA and GAPDH. (H) The band
intensities were quantified and represented as arbitrary units. Each blot/image is representative of three independent experiments,
and each column represents a mean of three values (asterisk represents significant value of P < .05).
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We next sought to analyze the effect of methylating agents on
uPA expression by treating cells with sodium butyrate. This treat-
ment downregulated uPA activity noticeably in both control and
irradiated cells (Figure 2, C and D). The reduction in uPA activ-
ity was observed to be a result of declines in protein and transcript
levels as shown by immunoblot analysis and RT-PCR, respectively
(Figure 2, C and D). In the subsequent experiments, we used dif-
ferent concentrations of methyltransferase inhibitor (zebularine) to
determine its influence on uPA expression. We noticed a dose-
dependent increase at the indicated concentrations in both cell lines
(Figure 2, E and F ). However, at higher concentrations, cell pro-
liferation was adversely affected (data not shown). In addition, we per-
formed experiments with zebularine in combination with radiation
and found that the combination treatment further increased uPA
expression in irradiated groups of both cell lines (Figure 2, G and
H ). Data from all of these experiments suggest that hypomethyl-
ation is the underlying event in radiation-induced uPA expression in
meningioma cells.
Radiation-Induced Hypomethylation Is Accompanied by
MEK/ERK Activation
On the basis of studies of human and mouse embryonic stem cells,
several signaling pathways have emerged as major candidate regulators
of epigenetic remodeling of gene expression [6]. In earlier studies, we
observed modulation of uPA expression in an ERK-dependent man-
ner [16,17]. We questioned whether this ERK dependence has any
role in radiation-induced hypomethylation. Radiation treatment
stimulated the phosphorylation of ERK 1 and 2 in both cell lines,
while the total forms remain unaffected (Figure 3A). The upstream
molecule MEK also responded similarly to ERK, showing increase
in activated MEK levels while the total forms remain unchanged
(Figure 3A). The increase in phosphorylation was found to be signif-
icant and more than two-fold in both cases (Figure 3, A and B). To
establish the upstream effects of these molecules, we also probed for
variations in epidermal growth factor receptor (EGFR) and Ras levels.
However, the results were not consistent (data not shown). Next, we
examined the effect of the ERK phosphorylation inhibitor (U0126).
Figure 3. Radiation-induced hypomethylation is accompanied by MEK/ERK activation. (A) Meningioma cells were irradiated at 7 Gy and
the cell lysates were immunoblotted for different molecules as indicated. (B) The band intensities were quantified and represented as
arbitrary units. (C) Meningioma cells were pretreated with U0126 (10 μM) for 30 minutes before radiation treatment and incubated over-
night in serum-free medium. Conditioned media were probed for uPA activity, and cell lysates were immunoblotted for different molecules.
(D) The band intensities were quantified and represented as arbitrary units. (E) Meningioma cells were pretreated with zebularine (50 μM) for
24 hours, and the cell lysates were immunoblotted for pERK and GAPDH. (F) The band intensities were quantified and represented as
arbitrary units. (G) Meningioma cells were pretreated with zebularine (50 μM) for 24 hours, and MTT assays were performed. Each blot/
image is representative of three independent experiments, and each column represents a mean of three values (asterisk represents signif-
icant value of P < .05).
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The inhibitor-treated cells showed a significant reduction in the
expression of uPA irrespective of radiation treatment (Figure 3, C and
D). An obvious decrease in the phosphorylation of MEK and ERK
coupled with a decline in the DNMT1 levels indicated the plausible
involvement of ERK in regulating the methylation status of DNA in
meningioma cells (Figure 3, C andD). Next, we analyzed the influence
of zebularine on ERK phosphorylation and found a gradual decrease
of pERK levels in a dose-dependent manner, suggesting a mutual de-
pendence of ERK and DNMT1 on one another (Figure 3, E and F ).
We extended our investigation to determine the effect of zebularine
on cellular proliferation. A decrement in the cellular proliferation was
apparent in both cell lines after 48 hours of treatment (Figure 3G ),
while increasing the dosage of zebularine killed most of the cells after
72 hours of treatment (Figure 3G ).
Small Interfering RNA (siRNA) Directed toward uPA
Promoter Prevents Radiation-Induced Hypomethylation
To identify the role of methylation in the TGS of uPA in menin-
gioma cells, we constructed a plasmid encoding shRNA against the
upstream sequences of the TATA box (Figure 4A). We also con-
structed and examined the effect of a vector containing scrambled
shRNA sequences on the methylation of uPA promoter. The con-
structs were sequence verified and used for further transfection stud-
ies. We first analyzed methylation status of the targeted regions.
Genomic DNA from transfected cells was chemically modified with
bisulfite treatment and subjected to MSP. Primers designed to
amplify the methylated regions yielded prominently high levels of
amplicons in puPA-transfected cells compared to respective untreated
cells (Figure 4B, MS primers). Cells treated with a combination of
Figure 4. siRNA directed toward the uPA promoter prevents radiation-induced hypomethylation. (A) Schematic depiction of the uPA
promoter showing shRNA target region, Sp1 binding sites, and the region selected for MSP. (B) IOMM-Lee and SF3061 (1 × 105) cells
were transfected with pSV or puPA for 36 hours before irradiation. After overnight incubation, bisulfite-treated genomic DNA was sub-
jected to MSP and followed by agarose gel analysis. (C) IOMM-Lee and SF3061 (1 × 105) cells were transfected with pSV or puPA for
36 hours before irradiation. After overnight incubation, conditioned media were subjected to fibrin zymography, total RNA was used to
perform RT-PCR, and cell lysates were used for immunoblot analysis as indicated. (D) The band intensities were quantified and repre-
sented as arbitrary units. (E) IOMM-Lee and SF3061 (1 × 105) cells were transfected with pSV or puPA for 36 hours before irradiation.
After overnight incubation, cells were fixed and subjected to immunocytochemistry with anti-uPA antibody (1:200) followed by HRP-
conjugated secondary antibody (1:500). The slides were treated with DAB, counterstained with hematoxylin, and observed under
×25 objective. Representative images of each treatment group are shown. (F) IOMM-Lee and SF3061 (1 × 105) cells were transfected
with pSV or puPA for 36 hours before irradiation. After overnight incubation, cells were transferred to transwell chambers coated with
matrigel (1 mg/ml) and allowed to invade for 24 hours. Percentage of invaded cells in each treatment group was calculated and plotted.
Each blot/image is representative of three independent experiments, and each column represents a mean of three values (asterisk
represents significant value of P < .05).
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radiation and pSV showed a remarkable decrease in the amplification,
illustrating the demethylation of target region in both cell lines
(Figure 4B, MS primers). In contrast, primers targeting unmethyl-
ated regions displayed significantly greater band intensities in cells
transfected with pSV and treated with radiation (Figure 4B, UM
primers). Accordingly, we observed very few or no amplicons in puPA-
transfected cells with these primers, which signifies siRNA-mediated
methylation in these cells (Figure 4B, UM primers). In addition,
transfection with puPA failed to induce DNA methylation in a non-
targeted 14-3-3 σ promoter, which is normally hypomethylated
in cells, indicating specific methylation of target regions (data
not shown).
We next tested if these changes in methylation patterns were trans-
formed to transcriptional gene regulation of uPA. Induction of meth-
ylation by puPA significantly reduced uPA expression at both the
mRNA and protein levels in these cells. Both uPA mRNA and pro-
tein were undetectable within 2 days of puPA transfection when
compared with pSV-transfected cells (Figure 4C ). We noticed a sig-
nificant decrease in the expression patterns of uPA expression in the
cells treated with a combination of puPA and radiation compared to
radiation treatment alone (Figure 4, C and D). Moreover, we
observed a marked reduction in the phosphorylation of ERK in
puPA-transfected cells (Figure 4C ). Next, we analyzed the in situ
cellular expression of uPA in cells transfected with puPA and pSV
and treated with radiation. As anticipated, we saw a remarkable
decrease in the overall expression of uPA in puPA-transfected cells
of both cell lines (Figure 4E ).
We further investigated whether the decrease in uPA expression
translated to the functional aspects of cells using invasion assays.
Cells transfected with puPA showed a more than 50% decrease in
Figure 5.MS transcription factors drive uPA expression in meningioma. (A) IOMM-Lee and SF3061 (1 × 105) cells were transfected with
pSV or puPA for 36 hours before irradiation. After overnight incubation, nuclear extracts were prepared and immunoblotted for the
indicated molecules. (B) The band intensities were quantified and represented as arbitrary units. (C) Meningioma cells were pretreated
with U0126 (10 μM) for 30 minutes before radiation treatment, and nuclear extracts were immunoblotted for different transcription
factors. (D) The band intensities were quantified and represented as arbitrary units. (E) IOMM-Lee and SF3061 (1 × 105) cells were
transfected with SV or puPA for 36 hours before irradiation. After overnight incubation, bisulfite-treated genomic DNA was subjected
to MSP and unmethylated PCR. (F) The band intensities were quantified and represented as arbitrary units. (G) The gel-purified ampli-
cons from previous experiments were digested with AciI and analyzed on 2% agarose gels. Each blot/image is representative of three
independent experiments, and each column represents a mean of three values (asterisk represents significant value of P < .05). Lamin
B1 was used as a loading control for nuclear extracts. SVM, scrambled vector methylation PCR amplicons; IRU, irradiation unmethylated
PCR amplicons.
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the number of invaded cells. Not surprisingly, irradiated cells trans-
fected with puPA showed a more than 70% decline in the invaded
cells compared to the cells treated with radiation alone (Figure 4F ).
These data indicate that induction of DNA demethylation of the
uPA gene promoter during radiation treatment could be blocked
by methylation induced by puPA transfection.
MS Transcription Factors Drive uPA
Expression in Meningioma
Previous studies using cell-free and in situ assays showed that
multiple transcription factors can bind to the uPA promoter and
thus regulate transcription of uPA gene expression [18]. Thus, we
first analyzed the modulation of Sp1, Ap1, phospho-cAMP response
element-binding protein (pCREB), and E2F1 in the nuclear extracts
of IOMM-Lee and SF3061 cell lines. Nuclear fractions of irradiated
cells showed the highest levels of Sp1, Ap1, and pCREB compared to
the other treatment groups (Figure 5, A and B). In contrast, nuclear
localization was apparently less in puPA-transfected cells treated with
or without radiation (Figure 5, A and B). Later, we tested the in-
fluence of ERK activation on the recruitment of Ap1 and pCREB
into the nucleus by treating the cells with U0126. Similar to puPA-
treated cells, we saw a drastic decrease in Sp1 and pCREB among
U0126-treated cells in both cell lines, which demonstrates the
role of ERK in Sp1 recruitment (Figure 5, C and D). We extended
our studies to determine the methylation status of Sp1 binding sites
upstream to TATA box of the uPA promoter (Figure 4A). We designed
two sets of primers to amplify a fragment of 120 bp including three
binding sites of Sp1 for MSP on bisulfite-treated genomic DNA. We
obtained amplification patterns similar to those described in Figure 4B
(Figure 5E ). Nevertheless, amplicons obtained in both reactions (with
MS primers and UM primers) were subjected to restriction digestion
with AciI after gel purification. Agarose gel analysis of the digested
molecules showed that the amplicons obtained by using MS primers
were digested to a smaller fragment compared to undigested controls
(Figure 5F ). In contrast, the amplicons obtained by primers spe-
cific for unmethylated DNA were not digested during the AciI treat-
ment, thereby indicating the lack of target site (Figure 5E ). These
results suggest that radiation treatment induces hypomethylation,
which, in turn, facilitates Sp1 binding to the consensus site and drives
uPA transcription.
Radiation Treatment Induces Hypomethylation In Vivo
We extended our studies on animal models to test whether the
in vitro observations held true in orthotopic tumors. Initially, the
Figure 6. Radiation treatment induces hypomethylation in vivo. Nude mice were intracranially implanted with IOMM-Lee cells as
described in the Materials and Methods section. (A) Formalin-fixed brain sections were subjected to H&E staining and observed under
×20 objective. Each image represents a brain section of five animals. (B) Total RNA was extracted from frozen brain tissues, and RT-PCR
was performed for uPA and GAPDH. Tissue lysates were analyzed for uPA expression by Western blot analysis. (C) The band intensities
of RT-PCR gels and Western blots were quantified and represented as arbitrary units. (D) Genomic DNA from frozen brain tissues was
extracted, treated with bisulfite, and subjected to MSP targeting the uPA promoter (MP, methylated primer; UMP, unmethylated primer).
(E) The band intensities were quantified and represented as arbitrary units. (F) Immunostaining with anti-DNMT1 antibody and non-
specific IgG (NsIgG) was performed on formalin-fixed brain sections from animals implanted with IOMM-Lee cells followed by treatment
with HRP-conjugated secondary antibody and DAB staining. Representative photomicrographs (×200) are shown in comparison to nor-
mal mouse brain sections. (G) Immunohistochemical analysis for DNMT1 was performed on tissue microarrays and clinical meningioma
samples. Representative images (×400) are shown. Each column represents a mean value of brain tissues from three different animals
(*P < .05, significant difference from respective normal tissues).
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formalin-fixed brains were sectioned, and H&E staining was per-
formed to confirm tumor formation. Apparent tumor formation
was evident in both control and irradiated groups of animals
(Figure 6A). Subsequently, snap-frozen brains were analyzed for
uPA expression at the RNA and protein levels; we found a marked
increase of uPA expression in the irradiated tumors compared to the
control (Figure 6B). The increase was found to be greater than five-
fold among irradiated tumors (Figure 6, B and C ). Further, we
extracted the genomic DNA from these tumors and subjected it to
bisulfite conversion followed by MSP to assess the methylation status.
As anticipated, hypomethylation was pronounced in irradiated cells
compared to the controls (Figure 6D). There was a two-fold change
in hypomethylation among the irradiated cells (Figure 6, D and E ).
Later, we performed immunohistochemical studies to visualize the
levels of DNMT1 in formalin-fixed and paraffin-embedded brain sec-
tions and found that the expression was very low in irradiated brain
sections compared to controls (Figure 6F ). Concomitantly, we per-
formed immunohistochemical analysis for DNMT1 in (malignant)
meningioma tissue array containing 80 clinical samples as well as
20 tumor sections to test whether global hypomethylation in menin-
gioma contributes to tumor progression. We assessed the expression
of DNMT1 in 60 samples. Among the positive sections, we observed
varied expression of DNMT1 in meningioma tissues with psammo-
matous tumors showing intense reactivity and fibrous tumors with
the least expression (Figure 6G ). Mixed and atypical tumors showed
moderate expression, whereas normal brain sections showed little
expression (Figure 6G ).
Discussion
Epigenetic mechanisms are known to contribute significantly to the
progression of meningioma with grade I and II tumors having more
aberrantly methylated loci [19]. Although not all aberrantly methyl-
ated CpG islands are expected to have an effect on gene expression, it
is evident that epigenetic mechanisms have a contributory role in
meningioma. It is well known that radiation treatment induces
genomic instability and manifests itself in induction of chromosomal
aberrations, aneuploidy, gene mutations and amplifications, micro-
satellite instability, and cell death [20,21]. Further, prominent hypo-
methylation during X-ray exposure, subsequent genome instability,
and resultant recruitment of repair machinery contributing signifi-
cantly to carcinogenesis have been reported in different tissues
[22,23]. It is also evident that most of the unmethylated CpGs are
located in the promoters of transcribed genes [24], and uPA promoter
hypomethylation has been recognized to be a causal, necessary, and
sufficient mechanism to drive transcription in prostate and breast
cancer cells [25–27]. In the present study, we hypothesized that
radiation-induced uPA expression in meningioma cells could be
because of promoter hypomethylation. Our initial studies on methyl-
ation status indicated that radiation did induce hypomethylation in
meningioma cells as evidenced by depleted expression of DNMT1,
MBP, and Mecp2 transcript levels. Similar to our observations, an
earlier study on hypomethylation induced by radiation treatment in-
dicated a decrease in DNMTs and Mecp2 in mammary tissues [22].
Further, pretreatment of cells with sodium butyrate quenched
radiation-induced expression of uPA, thereby providing evidence that
methylation has a role in uPA expression. Since oxidative damage has
been shown to interfere with MBPs resulting in heritable epigenetic
alterations [28], we treated cells with H2O2. Our results demonstrate
that uPA expression is not influenced by oxidative damage. This
observation suggests that radiation treatment induces changes in the
methylation patterns in an oxidative damage–independent fashion
among meningioma cells. In contrast to our findings, DNA methyl-
ation was found to be one of the determinants of γ radiation–induced
gene expression [29] and ultra violet B (UVB) radiation induced
DNMT activity to silence tumor suppressor genes, thereby support-
ing tumor growth [30], which perhaps suggests a complex network of
epigenetic events that can be initiated by ionizing radiation.
Genome-wide reduction in 5-methylcytosine is an epigenetic
hallmark of human tumorigenesis and experimentally induced hypo-
methylation in mice was shown to be sufficient to initiate tumori-
genesis [4]. Our experiments using MSP demonstrated that the
uPA promoter region underwent extensive hypomethylation after
radiation treatment. Similarly, the direct association between hypo-
methylation and uPA expression was also confirmed by azacytidine
treatment studies wherein pretreatment of cells with azacytidine
resulted in induction of uPA, which could not be further increased
by radiation treatment. These results indicate that the azacytidine
treatment induced total demethylation. Further, we have demon-
strated that demethylation within the uPA promoter can be reversibly
blocked by sodium butyrate (methylation agent) as seen by a decrease
in uPA expression, therefore suggesting that radiation has a direct
influence on the methylation patterns of the uPA gene promoter.
Apart from our present study, increase in methylation of uPA promoter
was found to correlate with lower levels of uPA and transcription
pattern of uPA in meningiomas [7], suggesting that uPA expression
might at least, in part, be controlled by promoter methylation.
Maintenance of the methylation patterns is sensitive to exogenous
and endogenous influences. However, signaling pathways involved in
DNA methylation/demethylation are not well understood. Experi-
mental overactivation of the Ras pathway [31], overexpression of
c-Myc [32], and overactivation of Shh [33], Wnt [34], and Notch
pathways [35] have been shown to perform a dynamic role in meth-
ylation among cancer cells. In light of these reports, and our prior
studies on ERK activation in meningioma cells [16], we assessed
the role of the ERK pathway in hypomethylation of the uPA pro-
moter. MEK kinase inhibitor treatment consistently blocked the
expression of uPA with concomitant decrease in DNMT1 levels sig-
nifying the role of the ERK pathway in uPA expression. Further, a
dose-dependent decrement in the activation of ERK upon zebularine
treatment also verified the association of ERK pathway with hypo-
methylation in meningioma cells. In contradiction to our results,
sodium arsenite was shown to induce death-associated protein kinase
(DAPK) promoter hypermethylation through ERK1/2 phosphoryla-
tion in human uroepithelial cells [36,37]. Likewise, down-regulation
of Ras activity reverted transformed morphology of Y1 cells with a
concomitant reduction in DNA methylation, DNA methyltransferase
mRNA, and enzymatic activity [38]. These conflicting findings illus-
trate that the cross talk between cell signaling and epigenetic control
is intricate and may often be tangled.
The development of promoter-targeted siRNA to achieve TGS
allows stable, long-lasting, and heritable epigenetic silencing of
tumor-promoting genes. In the present study, we designed siRNA
targeting CpG islands of the uPA promoter to inhibit uPA expression.
Kawasaki and Taira [9] reported that siRNA targeted to E-cadherin
promoter induced significant DNA methylation, which was depen-
dent on the DNA methyltransferases DNMT1 and DNMT3b, sug-
gesting that it occurred at the transcriptional level. Likewise, Morris
et al. [39] showed TGS of eukaryotic translation elongation factor-1
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alpha (EF-1α) in human embryonic kidney 293 (HEK293) cells using
promoter-specific siRNA. The studies of Castanotto et al. [8] demon-
strated that shRNA to the RASSF1A promoter induced partial gene
silencing. Murayama et al. [40] showed that shRNA against the hIL2
promoter dramatically reduced endogenous hIL2 expression. Taken
together, these studies suggest that TGS is an effective mechanism
for regulating gene expression in human cells. A marked reduction
of uPA transcription in siRNA-treated cells compared to respective
controls ensured that these meningioma cells already possess hemi-
methylated or partially methylated CpG islands in the uPA promoter.
Upon siRNA treatment, these CpG islands were completely methylated,
thereby abolishing uPA transcription. Additionally, our experiment
involving the pretreatment of cells with siRNA before irradiation
demonstrated the dominant effect of TGS over radiation treatment.
These results confirm that radiation-induced hypomethylation can be
surpassed by DNA methylation and quench uPA transcription.
It is well known that certain transcription factors, such as c-Myc,
do not bind to their recognition sequences in the methylated condi-
tion, suggesting that CpG methylation may affect the ability of Myc
to bind to multiple sites within the genome [41]. Given that Myc
can influence chromatin structure [42], it is certainly plausible that
inappropriate methylation of its recognition sites could have pro-
found implications on the cancer epigenome. Likewise, methylation
of cytosine in the flanking region adjacent to Sp1-binding consensus
directly reduces Sp1 binding [43]. This reduction in binding was re-
vealed to diminish p21Cip1 expression in response to depsipeptide
treatment [44]. Our results on nuclear extracts showing a rise of Sp1
levels during radiation treatment and occurrence of three Sp1 bind-
ing sites upstream to the transcription initiation site of uPA gene led
us to investigate the alterations in the methylation patterns on SP1
consensus. Further, in addition to direct activation of uPA gene
expression, Sp1 also interacts with and recruits other transcription
factors to the uPA promoter [45]. AciI digestion patterns of ampli-
cons suggested that radiation induces hypomethylation in Sp1 bind-
ing sites. However, puPA eradicated the recruitment of Sp1 into
nucleus. These results indicate the modulation of uPA promoter
by Sp1, which, in turn, is dependent on the methylation status of
its binding sites. Although the tumors obtained from animal models
revealed methylation patterns similar to our observations in cell lines,
the patterns of DNMT1 expression in clinical samples seem to fluc-
tuate, suggesting complex and context-dependent epigenetic regula-
tion in these tumors. Recently, hypermethylation of HOXA6,
HOXA9, PENK, UPK3A, and IGF2BP1 genes were shown to corre-
late with the recurrence of World Health Organization grade I and II
meningioma tumors [46]. Nevertheless, our investigation reveals that
hypomethylation of uPA promoter is a causal and necessary event for
the irradiation-induced aggressive behavior of meningioma.
Although DNA repair proteins were shown to contribute indi-
rectly to radiation-induced tumorigenesis, this study shows that the
irradiated cells acquire epigenetic changes, which suggests that epi-
genetic aberrations may arise in meningioma cells without initiating
chromosomal instability. Further, preferential epigenetic changes
seem to be more frequent than previously thought and suggest addi-
tional levels of uPA gene regulation.
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